Acquisition of LifeHealthcare, Equity Raising

Acquisition of LifeHealthcare, Equity Raising and Trading Update

EBOS Group Limited (EBOS) has entered into a share purchase agreement to acquire LifeHealthcare from Funds advised by Pacific Equity Partners and other minority holders, comprising 100% of LifeHealthcare’s Australian & New Zealand subsidiaries and 51% of LifeHealthcare’s Asian subsidiary, Transmedic (together, LifeHealthcare), for total consideration of approximately A$1,167 million (representing an enterprise value of approximately A$1,275 million on a 100% basis) subject to customary purchase price adjustments (the Acquisition or Transaction).

FUNDING

The Acquisition will be fully funded through a combination of the proceeds of a non-underwritten retail offer to eligible existing shareholders to raise up to A$100 million, with the ability to accept oversubscriptions at EBOS’ discretion, approximately A$642 million raised from the Placement, a new A$540 million term loan debt facility and approximately 0.7 million new EBOS shares issued to LifeHealthcare management (approximately $23 million ).

Please see attachments for full details.

---

Announcement PDF